[HTML][HTML] Current Non-Viral-Based Strategies to Manufacture CAR-T Cells
L Gehrke, VDR Gonçalves, D Andrae, T Rasko… - International journal of …, 2024 - mdpi.com
The successful application of CAR-T cells in the treatment of hematologic malignancies has
fundamentally changed cancer therapy. With increasing numbers of registered CAR-T cell …
fundamentally changed cancer therapy. With increasing numbers of registered CAR-T cell …
Efficient intracellular delivery of CRISPR-Cas9 ribonucleoproteins using dendrimer nanoparticles for robust genomic editing
CRISPR-Cas9, a flexible and efficient genome editing technology, is currently limited by the
challenge of delivering the large ribonucleoprotein complex intracellularly and into the …
challenge of delivering the large ribonucleoprotein complex intracellularly and into the …
CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations
The CRISPR-Cas9 technology, one of the groundbreaking genome editing methods for
addressing genetic disorders, has emerged as a powerful, precise, and efficient tool …
addressing genetic disorders, has emerged as a powerful, precise, and efficient tool …